Physician profile
Rafael Sierra
NPI 1801875901
$4,885,142.20
in general payments reported to CMS, 2019-2025
11 companies · $814K in 2025
The $814K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588K · 2020: $543K · 2021: $604K · 2022: $625K · 2023: $1.5M · 2024: $231K · 2025: $814K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.5M · Consulting Fee: $990K · Travel and Lodging: $34K · Food and Beverage: $5,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,496,121.52 |
| Consulting Fee | $989,540.00 |
| Travel and Lodging | $34,153.57 |
| Food and Beverage | $5,194.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,814,731.92 | 2019-2025 | G7, Vanguard Complete Knee Solution, Perfuse |
| Orthalign INC | $39,662.88 | 2019-2025 | Orthalign Plus |
| Think Surgical, INC. | $12,000.00 | 2019 | |
| Linkbio Corp | $9,341.35 | 2023 | |
| Ethicon US, LLC | $5,190.00 | 2025 | Ethicon, Vistaseal |
| Medacta USA, INC. | $2,308.99 | 2024-2025 | Mecta, Mypao |
| Gemini Medical LLC | $1,457.90 | 2022 | |
| Stryker Corporation | $166.88 | 2022 | |
| Gemini Mountain Medical, LLC | $152.33 | 2022 | |
| Depuy Synthes Sales INC. | $105.95 | 2019 | |
| Arthrex, INC. | $24.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Sierra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.